22.214.171.124 Treatment of pulmonary embolism and deep vein thrombosis and prevention of recurrent
|1st choice||Apixaban tablets 2.5mg, 5mg|
|2nd choices||Rivaroxaban 15mg, 20mg tablets|
|Dabigatran capsules 110mg, 150mg|
|Edoxaban 30mg, 60mg tablets|
|Warfarin tablets 1mg, 3mg|
- Refer to NICE guidance on anticoagulation treatment for venous thromboembolism (NICE make recommendations on preferred anticoagulant choices; these vary depending on co-morbidities/ clinical features. Apixaban is recommended first line in patients with no relevant co-morbidities or significant clinical features.)
- Please note dosing schedule. A number of incidents have been reported where the initial twice daily dose for rivaroxaban was continued beyond the 21 days following discharge from hospital, presenting a significant risk to patients. This type of incident is also possible with apixaban. Refer to BNF.